Europe acne treatment market size will reach USD 1,297.0

Pune, India, March 23, 2022 (GLOBE NEWSWIRE) — Europe acne treatment market size was estimated at the value 940.3 million USD in 2020. The market value should increase 928.7 million USD in 2021 for $1,297.0 million in 2028 at CAGR of 4.9% during the projected period. The growth may be closely linked to the increasing prevalence of acne and other skin disorders in the area. In the UK alone, over 95% of people aged 11 to 30 suffer from acne to some degree, according to the UK’s National Health Service (NHS). Fortune Business Insights presents this information in its report entitled “Acne Treatment Market in Europe, 2021-2028.”

Acne is a serious skin condition that occurs when hair follicles become clogged with dead skin cells and excess oil. The frequency of acne and related conditions among the European population, mainly adolescents and adults, has increased dramatically over the years. New solutions for the treatment of acne, both topical and oral, are being evaluated and commercialized in the region. In addition, several campaigns are launched to raise public awareness of these solutions. Citing one example, British skincare brand Ditch the Label hosts annual Acne Awareness Month to educate young people about acne. Such initiatives will certainly boost the adoption of acne skincare products across Europe.

Request a sample PDF:

Impact of COVID-19:

Acne care products are seeing lower demand due to lower dermatology consultations

The coronavirus pandemic has slightly affected the growth of the European acne treatment market. A noticeable drop in dermatology appointments was seen throughout 2020 due to stay-at-home orders in most European countries. Consequently, several market players have reported declining revenue from their acne and skin care businesses. For example, Spanish pharmaceutical brand Almirall, SA saw a 5% decline in revenue from its dermatology business in 2020 compared to 2019. Additionally, various clinical studies for acne products were postponed to 2020. Due to the aforementioned factors, acne treatment products have experienced a drop in demand during the COVID-19 pandemic.

To learn more about the short and long term impact of COVID-19 on this market, please visit:

Market segments:

The product, treatment modality, age group and distribution channel are researched for the market

On the basis of product, the market is categorized into antibiotics, retinoids, isotretinoin, and others.

By treatment modality, the market is split into topical and oral.

Based on age range, the market is divided into 10-17, 18-44, 45-64, and over 65.

By distribution channel, the market is divided between city pharmacies, hospital pharmacies and e-pharmacies.

Report scope and segmentation

Report cover Details
Forecast period 2021-2028
Forecast Period 2021 to 2028 CAGR 4.9%
2028 value projection $1,297.0 million
Year of reference 2020
Market size in 2021 $928.7 million
Historical data for 2017-2019
Number of pages 74
Segments Covered By type, by procedure, by geography
Growth engines The growing prevalence of acne and similar skin conditions among adolescents is contributing to the growth of the market in Europe.
The number of products including skin lotions and creams has been growing by major global and domestic players in Europe, which is driving the growth of the market.
The above mentioned factors and the presence of limited reimbursement scenario are expected to hamper the growth of the European acne treatment market during the forecast period.

Customization request:

Report cover

The report offers:

  • Key growth drivers, restraining factors, opportunities and potential challenges for the market.
  • A comprehensive overview of regional developments.
  • List of major industry players.
  • Key strategies adopted by market players.
  • The latest industry developments such as product launches, partnerships, mergers and acquisitions.

Drivers and Constraints:

Increase in the number of acne patients to increase acne treatment market share in Europe

Acne has become a major skin concern in Europe over the past decade. In the UK, the disease causes around 3.5 million primary care visits a year, according to the National Institute for Health and Excellence. In Italy, about 70-80% of people between the ages of 12 and 24 suffer from acne. Similar trends are seen in other European countries, which is fueling the adoption of acne treatment solutions. Ongoing R&D and the introduction of new products to the market will transform the regional landscape over the next few years.

On the other hand, some side effects associated with acne products might limit their demand in the region. For example, topical solutions can cause skin irritation and dryness. During this time, oral medications such as antibiotics can cause dizziness and lightheadedness.

Talk to the analyst:

Notable industry development:

February 2020 – Almirall, SA has announced that Seysara (sarecycline) – its first oral tetracycline antibiotic for acne vulgaris – is expected to be submitted to China’s National Medical Products Administration (NMPA) in 2023. Currently, Almirall owns the rights to marketing for the drug in the United States. It will develop it in China under a license agreement with Paratek Pharmaceuticals, Inc.

List of Key Players Featured in the Market Report:

  • Galderma SA (Lausanne, Switzerland)
  • GlaxoSmithKline plc. (London, UK)
  • Almirall, SA (Barcelona, ​​Spain)
  • Merck KGaA (Darmstadt, Germany)

Find out before you buy:


1. Introduction

1.1. Search scope

1.2. Market segmentation

1.3. Research Methodology

1.4. Definitions and assumptions

2. Executive Summary

3. Market dynamics

3.1. Market factors

3.2. Market constraints

3.3. Market opportunities

4. Key information

4.1. Prevalence of chronic and infectious diseases – Key countries/regions, 2019-2020

4.2. Key Industry Developments – Mergers, Acquisitions and Partnerships, 2020

4.3. Introduction of new products / approvals (by major players)

4.4. Impact of COVID-19 on the European acne treatment market

5. Europe Acne Treatment Market Analysis, Outlook and Forecast, 2017-2028

5.1. Main results/summary

5.2. Market Analysis, Outlook and Forecast – By Product

5.2.1. Retinoids

5.2.2. Antibiotics

5.2.3. Isotretinoin

5.2.4. Others

5.3. Market Analysis, Outlook and Forecast – By Treatment Modality

5.3.1. Oral

5.3.2. Topical

5.4. Market Analysis, Outlook and Forecast – By Age Group

5.4.1. 10 to 17 years old

5.4.2. 18 to 44 years old

5.4.3. 45 to 64 years old

5.4.4. Over 65

5.5. Market Analysis, Outlook and Forecast – By Distribution Channel

5.5.1. Hospital pharmacies

5.5.2. Retail pharmacies

5.5.3. E-pharmacies

6. Competitive analysis

6.1. Key Industry Developments

6.2. Market Share Analysis (2020)

6.3. Company Profiles (Overview, Products, SWOT, Recent Developments, Strategies, Financials (as available))

6.3.1. Galderma SA

6.3.2. GlaxoSmithKline plc.

6.3.3. Almirall, S.A.

6.3.4. Merck KGaA

7. Strategic Recommendations


About Us:

Fortune Business Insights™ delivers expert business analysis and accurate data, helping organizations of all sizes make timely decisions. We adapt innovative solutions to our customers, helping them to meet the challenges specific to their activities. Our goal is to give our clients holistic market intelligence, providing granular insight into the market they operate in.

Our reports contain a unique blend of tangible insights and qualitative analysis to help businesses achieve sustainable growth. Our team of experienced analysts and consultants use state-of-the-art research tools and techniques to compile comprehensive market research, interspersed with relevant data.

At Fortune Business Insights™, we aim to highlight the most lucrative growth opportunities for our clients. We therefore offer recommendations to help them navigate technological and market-related developments more easily. Our consulting services are designed to help organizations identify hidden opportunities and understand current competitive challenges.

Contact us:

Fortune Business Insights™ Pvt. ltd.

we: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

E-mail: [email protected]

About Sally Dominguez

Check Also

Norwest Venture Partners invests in Acne Skincare Brand Face Reality – WWD

Norwest Venture Partners enters acne care. The San Francisco-based investment firm has made a majority …